|1.||Wajner, Moacir: 2 articles (04/2003 - 05/2002)|
|2.||Wannmacher, Clóvis Milton Duval: 1 article (04/2003)|
|3.||Kessler, Adriana: 1 article (04/2003)|
|4.||Severo Dutra-Filho, Carlos: 1 article (04/2003)|
|5.||de Souza Wyse, Angela Terezinha: 1 article (04/2003)|
|6.||Costabeber, Elisa: 1 article (04/2003)|
|7.||Rech, Virginia Cielo: 1 article (05/2002)|
|8.||Feksa, Luciane Rosa: 1 article (05/2002)|
|9.||Wyse, Angela Terezinha de Souza: 1 article (05/2002)|
|10.||Wannmacher, Clovis Milton Duval: 1 article (05/2002)|
01/01/1981 - "Use of alpha-methylphenylalanine for studies of brain development in experimental phenylketonuria."
01/01/1986 - "The influence of alpha-methylphenylalanine-induced hyperphenylalaninaemia (HYP) on the lysosomal protein degradation system in brain and liver of suckling rats was investigated. "
01/17/1980 - "The model utilizing alpha-methylphenylalanine was relatively free from nonspecific effects and thus, changes observed in the animals were attributable to experimental phenylketonuria. "
04/01/1990 - "The present study was designed to provide further information on the enduring cognitive effects of experimental phenylketonuria (PKU) in rats, produced by the administration of alpha-methylphenylalanine and phenylalanine on postnatal days 3-21. "
06/01/1988 - "Supplementation of 5% phenylalanine plus 0.4% alpha-methylphenylalanine to the standard diet or 1% phenylalanine plus 0.08% alpha-methylphenylalanine to the drinking water produced phenylketonuria-like conditions in 5-day-old chicks. "
|2.||Body Weight (Weight, Body)
04/01/2003 - "Hyperphenylalaninemia was induced by subcutaneous administration of 5.2 micromol phenylalanine + 2.4 micromol alpha-methylphenylalanine (phenylalanine hydroxylase (PAH) inhibitor)/g of body weight. "
05/01/2002 - "HPA was induced by subcutaneous administration of 2.4 micromol/g body weight alpha-methylphenylalanine, a phenylalanine hydroxylase inhibitor, once a day, plus 5.2 microM/g body weight phenylalanine, twice a day, from the 6th-21st postnatal day. "
03/01/1983 - "In the first treatment, pregnant rats were injected subcutaneously with alpha-methylphenylalanine (to inhibit maternal liver phenylalanine hydroxylase) at a dosage of 30 mg/100 g body weight plus phenylalanine supplementation (to increase maternal and fetal plasma phenylalanine) at a dosage of 60 mg/100 g body weight two times daily. "
06/01/1999 - "Wistar rats were treated from the 6th to the 28th day of life with subcutaneous injections of either 2.6 micromol alanine or 5.2 micromol phenylalanine plus 2.6 micromol alpha-methylphenylalanine per g body weight or phenylalanine plus alpha-methylphenylalanine plus alanine in the same doses or equivalent volumes of 0.15 M saline. "
03/01/1983 - "High concentrations of phenylalanine were induced in pregnant rats from embryonic days 14 through 21 by subcutaneous injections of alpha-methylphenylalanine (mPhe) (to inhibit maternal phenylalanine hydroxylase) at a dosage of 30 mg/100 g body weight plus phenylalanine (Phe) supplementation (to raise fetal plasma phenylalanine) at a dosage of 60 mg/100 g body weight two times daily at 12-h intervals. "
09/15/1978 - "In contrast with p-chlorophenylalanine, alpha-methylphenylalanine did not exert these direct toxic effects because the administration of alpha-methylphenylalanine in vivo did not affect brain polyribosomes and a comparable concentration of this analogue was neither growth inhibitory nor cytotoxic to neuroblastoma cells in culture. "
09/15/1978 - "Effects of p-chlorophenylalanine and alpha-methylphenylalanine on amino acid uptake and protein synthesis in mouse neuroblastoma cells."
|4.||Acquired Immunodeficiency Syndrome (AIDS)
|2.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|5.||Neurotransmitter Agents (Neurotransmitter)
|6.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
|7.||Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)
|9.||Neutral Amino Acids